DGAP-Ad-hoc: HumanOptics AG / Key word(s): Personnel Erlangen, 15 January 2021 - The Supervisory Board of HumanOptics AG (ISIN DE000A1MMCR6) today appointed Stefan Kremer as the new Chief Executive Officer (CEO) to the company's Management Board effective 15 March 2021. In addition to the alignment and implementation of the corporate strategy, Stefan Kremer will focus on marketing and sales and will be responsible for the management of industry-specific departments. Stefan Kremer has many years of management experience in ophthalmology, including as Commercial Director at Kowa Pharmaceutical Europe Co. Ltd. Stefan Kremer holds a degree in industrial engineering and an MBA. HumanOptics will benefit from Stefan Kremer's extensive experience and wide-ranging network in ophthalmology and will be strengthened in its competitive position. His contract has a term of three years. In the future, the current CEO Diana Bachmann will mainly focus on the areas of finance, human resources and administration as Chief Financial Officer (CFO). End of ad hoc announcement
contact:
15-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | HumanOptics AG |
Spardorfer Str. 150 | |
91054 Erlangen | |
Germany | |
Phone: | +49 (0)9131 - 50665-60 |
Fax: | +49 (0)9131 - 50665-93 |
E-mail: | mail@humanoptics.com |
Internet: | www.humanoptics.de |
ISIN: | DE000A1MMCR6, DE000A255FK8 |
WKN: | A1MMCR |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart |
EQS News ID: | 1161035 |
End of Announcement | DGAP News Service |
1161035 15-Jan-2021 CET/CEST